Please provide your email address to receive an email when new articles are posted on . According to results from the ongoing Tsepamo study in Botswana, infants born to women who took the integrase ...
In a study published in the New England Journal of Medicine, women taking an HIV therapeutic drug containing dolutegravir have a higher risk of giving birth to children with neural tube defects ...
St. Louis, May 25, 2009 — Women of childbearing age can reduce the risk of having a child born with a neural tube defect such as spina bifida by eating enough folate or folic acid. However, folate ...
Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving ...
Please provide your email address to receive an email when new articles are posted on . According to results from the ongoing Tsepamo study in Botswana, infants born to women who took the integrase ...
SAN DIEGO, and GREENWOOD, S.C., March 24, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (BNGO), Inc. and Greenwood Genetic Center (GGC) today announced a publication in Genome Research describing the ...
Babies who were exposed to certain organic pollutants in the womb are at a highly increased risk of neural tube defects leading to conditions such as spina bifida, according to researchers in China.
Children born to women on HIV therapy containing the drug dolutegravir since conception have a slightly higher risk of neural tube defects, compared to children born to women on regimens of other ...
In about one out of every 1,000 pregnancies, the neural tube, a key nervous system structure, fails to close properly.
About 300,000 to 400,000 fetuses per year from mothers with diabetes develop neural tube defects -- when the tissue that eventually forms the brain and spinal cord fails to form properly -- which can ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results